The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals
Open accessAbstract
AIMS/HYPOTHESIS: Obesity is the dominant cause of insulin resistance. In adult humans it is characterised by a combination of adipocyte hypertrophy and, to a lesser extent, adipocyte hyperplasia. As hypertrophic adipocytes secrete more leptin and less adiponectin, the plasma leptin:adiponectin ratio (LAR) has been proposed as a potentially useful measure of insulin resistance and vascular risk. We sought to assess the usefulness of the LAR as a measure of insulin resistance in non-diabetic white adults. METHODS: Leptin and adiponectin levels were measured in 2,097 non-diabetic individuals from the Ely and European Group for the Study of Insulin Resistance (EGIR) Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study cohorts. LAR was compared with fasting insulin and HOMA-derived insulin sensitivity (HOMA-S) in all individuals and with the insulin sensitivity index (M/I) from hyperinsulinaemic-euglycaemic clamp studies in 1,226 EGIR RISC participants. RESULTS: The LAR was highly correlated with HOMA-S in men (r = -0.58, p = 4.5 x 10(-33) and r = -0.65, p = 1.1 x 10(-66) within the Ely and EGIR RISC study cohorts, respectively) and in women (r = -0.51, p = 2.8 x 10(-36) and r = -0.61, p = 2.5 x 10(-73)). The LAR was also strongly correlated with the clamp M/I value (r = -0.52, p = 4.5 x 10(-38) and r = -0.47, p = 6.6 x 10(-40) in men and women, respectively), similar to correlations between HOMA-S and the M/I value. CONCLUSIONS/INTERPRETATION: The leptin:adiponectin ratio is a useful measure of insulin resistance in non-diabetic white adults. These data highlight the central role of adipocyte dysfunction in the pathogenesis of insulin resistance. Given that variations between fasting and postprandial leptin and adiponectin levels tend to be small, the leptin to adiponectin ratio might also have potential value in assessing insulin sensitivity in the non-fasted state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529
The assessment of insulin resistance in man
Wallace, T. M., & Matthews, D. R. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00745.x · Cited by 677
Gavrila, A., Peng, C.-K., Chan, J. L., Mietus, J. E., Goldberger, A. L., & Mantzoros, C. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021721 · Cited by 360
The adipocyte as an active participant in energy balance and metabolism
Badman, M. K., & Flier, J. S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.058 · Cited by 256
Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications
Frystyk, J., Tarnow, L., Krarup Hansen, T., Parving, H.-H., & Flyvbjerg, A. (2005) · Diabetologia · doi:10.1007/s00125-005-1850-z · Cited by 223
Self-citationLeptin-to-Adiponectin Ratio as a Potential Atherogenic Index in Obese Type 2 Diabetic Patients
Satoh, N., Naruse, M., Usui, T., Tagami, T., Suganami, T., Yamada, K., Kuzuya, H., Shimatsu, A., & Ogawa, Y. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2488 · Cited by 207
The ratio of leptin to adiponectin can be used as an index of insulin resistance
Oda, N., Imamura, S., Fujita, T., Uchida, Y., Inagaki, K., Kakizawa, H., Hayakawa, N., Suzuki, A., Takeda, J., Horikawa, Y., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2007.09.011 · Cited by 192
Adipose Tissue Expandability in the Maintenance of Metabolic Homeostasis
Gray, S. L., & Vidal-Puig, A. J. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00331.x · Cited by 190
Report prepared on behalf of the EGIR-RISC Study Group, Hills, S. A., Balkau, B., Coppack, S. W., Dekker, J. M., Mari, A., Natali, A., Walker, M., & Ferrannini, E. (2004) · Diabetologia · doi:10.1007/s00125-004-1335-5 · Cited by 179
Self-citationUndiagnosed Glucose Intolerance in the Community: the Isle of Ely Diabetes Project
Williams, D. R. R., Wareham, N. J., Brown, D. C., Byrne, C. D., CLARK, P. M. S., Cox, B. D., Cox, L., Day, N., Hales, C. N., Palmer, C., et al. (1995) · Diabetic Medicine · doi:10.1111/j.1464-5491.1995.tb02058.x · Cited by 163
Self-citationAdipose Tissue Expandability in the Maintenance of Metabolic Homeostasis
Gray, S. L., & Vidal-Puig, A. J. (2007) · Nutrition Reviews · doi:10.1301/nr.2007.jun.s7-s12 · Cited by 158
Elevated Plasma Adiponectin in Humans with Genetically Defective Insulin Receptors
Semple, R. K., Soos, M. A., Luan, J., Mitchell, C., Wilson, J. C., Gurnell, M., Cochran, E. K., Görden, P., Chatterjee, K., Wareham, N. J., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0166 · Cited by 144
Self-citationSemple, R. K., Halberg, N., Burling, K., Soos, M. A., Schraw, T., Luan, J., Cochran, E. K., Dunger, D. B., Wareham, N. J., Scherer, P. E., et al. (2007) · Diabetes · doi:10.2337/db06-1665 · Cited by 110
Self-citationZhuo, Q., Wang, Z., Fu, P. P., Piao, J., Tian, Y., Xu, J., & Yang, X. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.12.019 · Cited by 108
Adiponectin and Leptin in African Americans
Considine, R. V., Premkumar, A., Reynolds, J. C., Sebring, N. G., Ricks, M., & Sumner, A. E. (2008) · Obesity · doi:10.1038/oby.2007.80 · Cited by 33
Hung, Y.-J., Chu, N.-F., Wang, S., Hsieh, C.-H., HE, C.-T., Lee, C.-H., & FAN, S.-C. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.00909.x · Cited by 28
Cited by
Harvie, M. N., Pegington, M., Mattson, M. P., Frystyk, J., Dillon, B., Evans, G., Cuzick, J., Jebb, S. A., Martin, B., Cutler, R. G., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.171 · Cited by 804
Self-citationDavidovici, B. B., Sattar, N., Jörg, P. C., Puig, L., Emery, P., Barker, J. N., van de Kerkhof, P., Ståhle, M., Nestle, F. O., Girolomoni, G., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.103 · Cited by 711
Er, L.-K., Wu, S., Chou, H.-H., Hsu, L.-A., Teng, M.-S., Sun, Y.-C., & Ko, Y.-L. (2016) · PLOS ONE · doi:10.1371/journal.pone.0149731 · Cited by 708
Srikanthan, K., Feyh, A., Visweshwar, H., Shapiro, J. I., & Sodhi, K. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.13800 · Cited by 443
Harvie, M., Wright, C., Pegington, M., McMullan, D., Mitchell, E., Martin, B., Cutler, R. G., Evans, G., Whiteside, S., Maudsley, S., et al. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513000792 · Cited by 431
Metadata
- Authors
- (on behalf of the European Group for the Study of Insulin Resistance: Relationship between Insulin Sensitivity and Cardiovascular Disease Risk Study Group), Finucane, F. M., Luan, J., Wareham, N. J., Sharp, S. J., O’Rahilly, S., Balkau, B., Flyvbjerg, A., Walker, M., Højlund, K., Nolan, J. J., & Savage, D. B.
- Venue
- Diabetologia
- Published
- 2009-09-12
- Volume
- 52
- Issue
- 11
- Pages
- 2345-2349
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1968441810
- Cited by
- 302
- References
- 16
- FWCI
- 10.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.